Biogen Non-GAAP EPS of $4.02 beats by $0.26, revenue of $2.46B beats by $100M
Biogen press release  (NASDAQ:BIIB): Q2  Non-GAAP EPS of $4.02  beats by $0.26.
Revenue of $2.46B (-5.0% Y/Y)  beats by $100M.
FY23 Outlook:
Total revenue growth in mid-single digit percentage decline Y/Y.
Non-GAAP EPS of $15.00-$16.00 vs $15.43 consensus.